ストックスクリーナーアプリを入手
3.29
2.66%
-0.09
プレマーケット:
3.28
-0.01
-0.30%
前日終値:
$3.38
開ける：
$3.37
24時間の取引高:
890.15K
Relative Volume:
0.89
時価総額：
$158.58M
収益：
$219.42M
当期純損益:
$-15.09M
株価収益率:
-7.9106
EPS:
-0.4159
ネットキャッシュフロー:
$-3.05M
1週間 パフォーマンス:
-10.60%
1か月 パフォーマンス:
-29.09%
6か月 パフォーマンス:
+17.50%
1年 パフォーマンス:
-51.83%
1日の値動き範囲:
$3.1964
$3.40
1週間の範囲:
$3.00
$3.71
52週間の値動き範囲:
$2.56
$7.32
Lifemd Inc Stock (LFMD) Company Profile
Compare LFMD vs VEEV, BTSG, TEM, HQY, TXG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
3.29 | 162.92M | 219.42M | -15.09M | -3.05M | -0.4159 |
VEEV
Veeva Systems Inc
|
241.51 | 38.43B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
59.68 | 11.45B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.61 | 10.05B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
105.50 | 8.83B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
57.75 | 7.62B | 638.78M | -22.66M | 122.18M | -0.1744 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-16 | アップグレード | Mizuho | Neutral → Outperform |
| 2025-06-18 | 繰り返されました | BTIG Research | Buy |
| 2024-12-10 | 開始されました | Lake Street | Buy |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-08-23 | 再開されました | B. Riley Securities | Buy |
| 2024-06-05 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | 開始されました | Craig Hallum | Buy |
| 2023-07-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-07-03 | 開始されました | H.C. Wainwright | Buy |
| 2022-03-10 | 開始されました | Colliers Securities | Buy |
| 2021-10-04 | 再開されました | B. Riley Securities | Buy |
すべてを表示
Lifemd Inc (LFMD) 最新ニュース
LifeMD, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:LFMD) 2026-08-11 - Seeking Alpha
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Cuts Target Price to $9 - Moomoo
Renaissance Technologies LLC Trims Stock Holdings in LifeMD, Inc. $LFMD - MarketBeat
LifeMD Inc (LFMD) Stock News Today - TradingKey
LifeMD, Inc. (LFMD) stock price, news, quote and history - Yahoo Finance Singapore
LFMD Maintains Buy Rating by HC Wainwright & Co. -- Price Target Lowered to $9.00 - GuruFocus
LifeMD (NASDAQ:LFMD) Price Target Lowered to $9.00 at HC Wainwright - MarketBeat
LFMD Maintained by B. Riley Securities -- Price Target Lowered t - GuruFocus
LifeMD, Inc. Stock 12‑Month Price Target Cut to $9, Implies 145% Upside - tradingview.com
LifeMD (NASDAQ:LFMD) Price Target Cut to $8.00 by Analysts at B. Riley Financial - MarketBeat
B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating - Moomoo
LifeMD, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
LFMD Maintained by BTIG -- Price Target Lowered to $9.00 - GuruFocus
BTIG Research Lowers LifeMD (NASDAQ:LFMD) Price Target to $9.00 - MarketBeat
(LFMDP) Risk Channels and Responsive Allocation - Stock Traders Daily
LFMD Looks 36.9% Undervalued on GF Value™ Despite Revenue Foreca - GuruFocus
LFMD Looks 36.9% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
LifeMD earnings missed by $0.06, revenue fell short of estimates - Investing.com South Africa
LifeMD (NASDAQ:LFMD) Issues Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
LifeMD Inc reports results for the quarter ended June 30Earnings Summary - tradingview.com
LifeMD Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: LifeMD posts Q2 revenue miss, shares sink in after-hours - Investing.com
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
UPDATELifeMD Reports Second Quarter 2026 Results - The Manila Times
Is LifeMD Inc (LFMD) Undervalued After Q2 Earnings Miss? EPS of - GuruFocus
LifeMD August 2026 slides: growth vision meets Q2 execution gap - Investing.com
LifeMD Q2 2026 slides tout AI platform, results miss targets - Investing.com
LifeMD, Inc. Q2 2026: Revenue $47.28M, EPS $(0.16) — 10-Q Summary - tradingview.com
LifeMD Q2 revenue misses estimates as shift to branded GLP-1 therapies weighs - tradingview.com
LifeMD (NASDAQ: LFMD) posts $15.96M loss but holds $25.1M cash and $30M credit line - Stock Titan
LIFEMD REPORTS SECOND QUARTER 2026 RESULTS - Moomoo
LifeMD, Inc. Provides Earnings Guidance for the Third Quarter and Fourth Quarter of 2026 - marketscreener.com
LifeMD posts Q2 2026 revenue of $47.3M, narrows adjusted EBITDA loss, expects profitability in H2 - Pluang
Earnings To Watch: LifeMD Inc (LFMD) Q2 2026 -- GF Value Sees 92% Upside - Yahoo Finance
LFMD|LifeMD Inc|Price:3.735|Chg%:+0.235 - TradingKey
LFMD Q2'26 Earnings: revenue estimate is 49.16M USD - TradingView
LifeMD (LFMD) Projected to Announce Quarterly Earnings on Wednesday - MarketBeat
LifeMD Inc (LFMD) Institutional Confidence - TradingKey
LifeMD Inc (LFMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LFMD|LifeMD Inc|Price:3.875|Chg%:+0.165 - TradingKey
LifeMD Inc (LFMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LifeMD Inc (LFMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
LifeMD Inc (LFMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LifeMD Inc (LFMD) Balance Sheet - TradingKey
LifeMD Inc (LFMD) Earnings Date & Reports & Earnings News - TradingKey
LifeMD Inc (LFMD) Income Statement - TradingKey
LFMD|LifeMD Inc|Price:3.710|Chg%:-0.160 - TradingKey
Lifemd, Inc. (LFMD) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Lifemd, Inc. (LFMD) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
LifeMD to Report Second Quarter 2026 Financial Results on August 5 - The Manila Times
LifeMD schedules Aug. 5 update after U.S. markets close - Stock Titan
Lifemd Inc (LFMD) 財務データ
収益
当期純利益
現金流量
EPS
Lifemd Inc (LFMD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| FRIEDEMAN JESSICA | Chief Marketing Officer |
Dec 09 '25 |
Sale |
3.61 |
15,000 |
54,158 |
205,000 |
1.05%
2.00%
大文字化:
|
ボリューム (24 時間):